Search research articles
Contact Us
Filters
Showing results (301-310 of 382) with videos related to
Page
of 39
Sort By:
Gynecologic Oncology
|
September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Genomics
|
September 19, 1998
Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval
S Peiffer-Schneider, F C Noonan, D G Mutch, et al.
American Journal of Human Genetics
|
September 1, 1985
Linkage analysis of a DNA marker localized to 20p12 and multiple endocrine neoplasia type 2A
P J Goodfellow, B N White, J J Holden, et al.
Journal of the National Cancer Institute
|
September 3, 2015
Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer
Christopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Journal of Proteome Research
|
January 21, 2022
NMR Metabolomics Assessment of Osteogenic Differentiation of Adipose-Tissue-Derived Mesenchymal Stem Cells
Daniela S C Bispo, Catarina S H Jesus, Marlene Correia, et al.
Journal of Proteome Research
|
December 13, 2012
Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine
Sílvia O Diaz, António S Barros, Brian J Goodfellow, et al.
Carcinogenesis
|
November 5, 2014
NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma
Cláudia M Rocha, António S Barros, Brian J Goodfellow, et al.
Gynecologic Oncology
|
April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessment
Casey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Journal of Proteome Research
|
April 25, 2013
Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes
Sílvia O Diaz, António S Barros, Brian J Goodfellow, et al.
Oncotarget
|
October 6, 2017
Novel <i>SOX17</i> frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations
Christopher J Walker, Matthew J O'Hern, Vanida A Serna, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 382) with videos related to
Sort By:
Page
of 39
Gynecologic Oncology
|
September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Genomics
|
September 19, 1998
Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval
S Peiffer-Schneider, F C Noonan, D G Mutch, et al.
American Journal of Human Genetics
|
September 1, 1985
Linkage analysis of a DNA marker localized to 20p12 and multiple endocrine neoplasia type 2A
P J Goodfellow, B N White, J J Holden, et al.
Journal of the National Cancer Institute
|
September 3, 2015
Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer
Christopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Journal of Proteome Research
|
January 21, 2022
NMR Metabolomics Assessment of Osteogenic Differentiation of Adipose-Tissue-Derived Mesenchymal Stem Cells
Daniela S C Bispo, Catarina S H Jesus, Marlene Correia, et al.
Journal of Proteome Research
|
December 13, 2012
Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine
Sílvia O Diaz, António S Barros, Brian J Goodfellow, et al.
Carcinogenesis
|
November 5, 2014
NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma
Cláudia M Rocha, António S Barros, Brian J Goodfellow, et al.
Gynecologic Oncology
|
April 5, 2025
Exploring endometrial cancer risk stratification by copy number assessment
Casey M Cosgrove, Adrian A Suarez, Paulina J Haight, et al.
Journal of Proteome Research
|
April 25, 2013
Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes
Sílvia O Diaz, António S Barros, Brian J Goodfellow, et al.
Oncotarget
|
October 6, 2017
Novel <i>SOX17</i> frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations
Christopher J Walker, Matthew J O'Hern, Vanida A Serna, et al.
Page
of 39